Lv2
138 积分 2023-09-07 加入
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality
3天前
已完结
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality
3天前
已完结
Considerations on Interim Evaluation of OS in Pivotal Oncology Trials
4个月前
已完结
Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group
5个月前
已完结
Robust Design and Analysis of Clinical Trials With Non-proportional Hazards: A Straw Man Guidance from a Cross-pharma Working Group
5个月前
已关闭
Critical review of oncology clinical trial design under non-proportional hazards
5个月前
已完结
Statistical considerations for evaluating treatment effect under various non-proportional hazard scenarios
5个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
6个月前
已完结
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
8个月前
已完结
M-DODII: Bayesian dose optimization design for randomized phase II study with multiple indications
8个月前
已完结
皖公网安备34019202002308
